EBGLYSS
EBGLYSS
Approved
DIN Number
02549123
Drug Class
Human
Market Date
Sep 19, 2024
Company
HC
eli lilly canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02549123
AIG Number0165983001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
D11AH10 LEBRIKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
LEBRIKIZUMABActive
Strength: 250 MG / 2 ML
Monograph: LEBRIKIZUMAB